| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |